1. Wang, Yunhan, Zhao, Yu, Zhang, Zongying, Zhou, Xiaorong, Mao, Liming. 2023. High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity. In Genes, 14, . doi:10.3390/genes14071406. https://pubmed.ncbi.nlm.nih.gov/37510310/
2. Li, Hongyi, Wang, Shaojie, Li, Xiubo, Cheng, Xiaolong, Cui, Yongping. 2022. CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC. In Cancer science, 114, 91-104. doi:10.1111/cas.15560. https://pubmed.ncbi.nlm.nih.gov/36056599/
3. Guo, Yu, Zhou, Kaimei, Zhuang, Xiang, Li, Junjie, Shen, Xianglin. 2021. CDCA7-regulated inflammatory mechanism through TLR4/NF-κB signaling pathway in stomach adenocarcinoma. In BioFactors (Oxford, England), 47, 865-878. doi:10.1002/biof.1773. https://pubmed.ncbi.nlm.nih.gov/34339079/
4. Goto, Yuya, Hayashi, Reiko, Muramatsu, Tomoki, Ohtani, Kiyoshi, Yoshida, Kenichi. 2006. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. In Biochimica et biophysica acta, 1759, 60-8. doi:. https://pubmed.ncbi.nlm.nih.gov/16580749/
5. Shinkai, Akeo, Hashimoto, Hideharu, Shimura, Chikako, Kurumizaka, Hitoshi, Shinkai, Yoichi. . The C-terminal 4CXXC-type zinc finger domain of CDCA7 recognizes hemimethylated DNA and modulates activities of chromatin remodeling enzyme HELLS. In Nucleic acids research, 52, 10194-10219. doi:10.1093/nar/gkae677. https://pubmed.ncbi.nlm.nih.gov/39142653/
6. Jiménez-P, Raúl, Martín-Cortázar, Carla, Kourani, Omar, Iglesias, Teresa, Campanero, Miguel R. 2018. CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth. In Haematologica, 103, 1669-1678. doi:10.3324/haematol.2018.188961. https://pubmed.ncbi.nlm.nih.gov/29880607/
7. Duran, Tugce, Karaselek, Mehmet Ali, Kuccukturk, Serkan, Keles, Sevgi, Reisli, Ismail. 2024. Investigation of Transcription Factor and Cytokine Gene Expression Levels in Helper T Cell Subsets Among Turkish Patients Diagnosed with ICF2 (Novel ZBTB24 gene Variant) and ICF3 (CDCA7 Variant) Syndrome. In Journal of clinical immunology, 45, 16. doi:10.1007/s10875-024-01807-5. https://pubmed.ncbi.nlm.nih.gov/39320531/